Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system
Related Experiment Video
Updated: Aug 23, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Koichi Setsuta1, Yoshihiko Seino, Takeshi Ogawa
1Division of Cardiology, Department of Medicine, Tokyo Metropolitan Komagome Hospital, Japan.
Insights
Elevated heart-type fatty acid-binding protein (H-FABP) indicates ongoing myocardial damage in chronic heart failure (CHF). This damage is linked to increased tumor necrosis factor (TNF) and Fas/Fas ligand (FasL) system activation.
Area of Science:
- Cardiology
- Biomarkers
- Heart Failure Pathophysiology
Background:
- Elevated cardiac troponin T and H-FABP identify chronic heart failure (CHF) patients with ongoing myocardial damage (OMD) at high risk.
- Cardiomyocyte necrosis/apoptosis via TNF and Fas/FasL may contribute to OMD development.
Purpose of the Study:
- To investigate the relationship between H-FABP, TNF, and Fas/FasL system activation in CHF patients.
- To assess if these markers correlate with heart failure severity.
Main Methods:
- Serum concentrations of H-FABP, soluble Fas (sFas), and TNF-alpha were measured in 38 CHF patients.
- Patients were categorized by New York Heart Association (NYHA) functional class (II vs. III+IV).
- Correlations between markers and renal function were analyzed.
Main Results:
- H-FABP, TNF-alpha, and sFas levels were significantly higher in NYHA III+IV patients compared to NYHA II patients.
- Increased H-FABP concentrations strongly correlated with elevated TNF-alpha (r=0.57, p=0.0001) and sFas (r=0.69, p<0.0001).
- These correlations were independent of renal function.
Conclusions:
- OMD, indicated by H-FABP, is associated with activated TNF and the Fas/FasL system in CHF.
- This suggests a pathophysiological role for cardiomyocyte necrosis/apoptosis in worsening heart failure.
- H-FABP serves as a marker for membrane damage related to these inflammatory pathways.
Background:
Elevated concentrations of cardiac troponin T and heart-type fatty acid-binding protein (H-FABP) identify patients with chronic heart failure (CHF) and ongoing myocardial damage (OMD) who are at increased risk for future cardiac events. Cardiomyocyte necrosis and/or apoptosis via activated tumor necrosis factor (TNF) and the Fas/Fas ligand (FasL) system may be related to the development of OMD.
Methods And Results:
The serum concentrations of H-FABP, a sensitive marker of membrane damage of cardiomyocytes, soluble Fas (sFas) and TNF-alpha were measured in 38 patients with CHF. The concentrations of H-FABP, TNF-alpha and s-Fas in patients with New York Heart Association (NYHA) III + IV were all significantly higher than in those patients in NYHA II (H-FABP; III + IV 9.3+/-5.9 vs II 5.1+/-1.8 ng/ml, p=0.003, TNF-alpha; III + IV 10.5+/-3.8 vs II 8.0+/-2.7 pg/ml, p=0.02, sFas; III + IV 3.36+/-1.37 vs II 2.58 +/-0.84 ng/ml, p=0.03). Increased concentrations of H-FABP significantly correlated with the concentrations of TNF- alpha (r=0.57, p=0.0001) and sFas (r=0.69, p<0.0001), independent of renal function.
Conclusion:
OMD detected by H-FABP, a marker of membrane damage, is related to activated TNF and the Fas/FasL system, which suggests a pathophysiological role of cardiomyocyte necrosis and/or apoptosis in patients with worsening heart failure.
Related Concept Videos
Pathophysiology of Heart Failure
Myocarditis I: Introduction
Chronic Inflammation: Introduction
Heart Failure II: Pathophysiology
The Extrinsic Apoptotic Pathway
Cirrhosis II: Pathophysiology
